Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2924 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42651 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43141 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104347 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106913 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110779 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-16 | 2020-04-23 | 112382 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-16 | 2021-01-28 | 120497 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-07-16 | 2020-07-23 | 120500 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120908 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120914 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-08-20 | 2020-12-17 | 122685 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2023-06-08 | 2023-06-21 | 194077 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195459 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-20 | 2023-10-03 | 199284 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-10-19 | 2024-01-11 | 207497 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2024-02-08 | 2025-01-30 | 218940 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2024-06-07 | 2024-06-27 | 229936 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Actual shortage | 2025-10-16 | 2025-10-16 | 269664 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258565 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258616 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258619 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260534 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258577 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258768 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258783 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258484 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258496 |